Global Wound Care Biologics Market to reach USD 2.9 billion by 2025 | CAGR:10.1%

Global Wound Care Biologics Market is valued at USD 1.2 billion in 2016 is anticipated to grow USD 2.9 billion with the compounded annual growth of 10.1% over the forecast period 2017-2025.

 

New York 1 June 2018, As per the new research study conducted by Bizwit Research & Consulting, Global Wound Care Biologics industry is poised to raise USD 2.9 billion by 2025. The driving factor for the wound biological market is the rising prevalence of chronic wounds such as diabetic foot ulcers, leg ulcers, as well as; increasing incidents of burns; and growing number of fire accidents. and increasing harmful accidents involving the use of acid, skin diseases, and surge in the number of body surgeries are likely to pump-up the global wound biologics market during the forecast period. To view the summary or to request a sample copy of this report, please click the link mentioned below:

 

Global Wound Care Biologics Market Size Estimates and By Wound Type (Ulcers, Surgical and Traumatic Wounds, Burns) By End User (Hospitals, ASCs, Burn Centres and Wound Clinics) and by Region (North America, Europe, Asia Pacific, and Rest of the World) 2017-2025

 

The industry is seeming to be fairly competitive. Some of the leading market players include Smith & Nephew plc, Integra Life Sciences Corporation, B. Braun Melsungen AG, Mölnlycke Health Care AB, 3M Healthcare, Ethicon, Inc. (Johnson & Johnson), Hill-Rom Holdings, Inc., Cardinal Health, Acelity L.P., Inc., ConvaTec Inc., BSN medical (Svenska Cellulosa Aktiebolaget SCA), Coloplast Group. New product launches, acquisitions, and mergers are some of the strategies adopted by the key manufacturers. Additionally, the fierce competitiveness has made these players spend in product developments to improve the customer’s requirements.

Key findings of the study:

  • The North America region estimated for dominating the Wound Care Biologics market during the forecast period.
  • The North America region will be the highest growing segment with respect to geographical segmentation by around XX%
  • Asia PacificWound Care Biologics market is estimated to grow at the highest CAGR during the forecast period.

 

Bizwit Research & Consulting LLP has considered the following segments for the study:

 

  • By Wound Type
  • Ulcers
  • Surgical and Traumatic Wounds
  • Burns
  • By End User
  • Hospitals
  • ASCs
  • Burn Centers and Wound Clinics

Regional Outlook

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

 

To get a sample of this report or to purchase a copy of the study, you can directly contact us. Or mail to us at sales@bizwitresearch.com

 

how can we help you?

For any specific query or to receive regular updates of our latest titles fill the details on the contact form or in the subscription box down below. Trust us, we hate spams too. You will only get the regular updates and quality contents.

Loading…